Literature DB >> 6156957

Alteration in the metabolism of dihydrotestosterone in elderly men with prostate hyperplasia.

I Morimoto, A Edmiston, R Horton.   

Abstract

In vivo androgen kinetics were determined in six young (21--49 yr) and elderly men (62-77 yr) with prostatge hyperplasia (BPH). Steady-state infusions of [14C]testosterone and [3H]androstanediol (3 alpha diol) were given, which allowed determination of the conversions testosterone leads to dihydrotesterone (DHT) in equilibrium or formed from 3 alpha diol. These infusions also yield metabolic clearance data which, together with meaurement of nonisotopic steroid levels, yield estimations of blood production rates. The production rate for testosterone was 6.04 +/- 1.66 vs. 3.69 +/- 0.62 mg/d, whereas the production rate for 3 alpha diol was 319 +/- 57 and 193 +/- 34 micrograms/d (P < 0.05 both groups). The irreversible conversion rate of testosterone to DHT was 3.1 +/- 0.4 and 3.5 +/- 0.9% (NS). The back conversion of 3 alpha diol to dHT was high (68 +/- 25 vs. 81 +/- 17, NS) indicating that 3 alpha diol might cause BPH as a result of conversion to DHT in vivo. The conversion of DHT to 3 alpha diol is reduced in the elderly group (15.8 +/- 2.6 and 6.3 +/- 1.4, P < 0.001). Since DHT formation in the prostate is a key event in the development of BPH and blood DHT appears to be a measure of extrasplanchnic sexual target tissue activity, our in vivo studies suggest that the tissue increase in DHT may result from reduced metabolism and the activity of 3 alpha-oxidoreduction favors the oxidative pathway in elderly men.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6156957      PMCID: PMC371692          DOI: 10.1172/JCI109895

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Simultaneous radioimmunoassay of testosterone and dihydrotestosterone.

Authors:  J M Barberia; I H Thorneycroft
Journal:  Steroids       Date:  1974-05       Impact factor: 2.668

2.  In vivo conversion of dehydroisoandrosterone to plasma androstenedione and testosterone in man.

Authors:  R Horton; J F Tait
Journal:  J Clin Endocrinol Metab       Date:  1967-01       Impact factor: 5.958

3.  The conversion of testosterone to 5-alpha-androstan-17-beta-ol-3-one by rat prostate in vivo and in vitro.

Authors:  N Bruchovsky; J D Wilson
Journal:  J Biol Chem       Date:  1968-04-25       Impact factor: 5.157

4.  A specific radioimmunossay for testosterone in peripheral plasma.

Authors:  T Kinouchi; L Pages; R Horton
Journal:  J Lab Clin Med       Date:  1973-08

5.  Age related changes and interrelationships between plasma testosterone, oestradiol and testosterone-binding globulin in normal adult males.

Authors:  K M Pirke; P Doerr
Journal:  Acta Endocrinol (Copenh)       Date:  1973-12

6.  The intranuclear binding of testosterone and 5-alpha-androstan-17-beta-ol-3-one by rat prostate.

Authors:  N Bruchovsky; J D Wilson
Journal:  J Biol Chem       Date:  1968-11-25       Impact factor: 5.157

7.  Metabolism of testosterone and action of metabolites on prostate glands grown in organ culture.

Authors:  E E Baulieu; I Lasnizki; P Robel
Journal:  Nature       Date:  1968-09-14       Impact factor: 49.962

8.  Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man.

Authors:  P K Siiteri; J D Wilson
Journal:  J Clin Invest       Date:  1970-09       Impact factor: 14.808

9.  A comparative study of the conversion of testosterone to 17-beta-hydroxy-5-alpha-androstan-3-one (Dihydrotestosterone) by prostate and epididymis.

Authors:  R E Gloyna; J D Wilson
Journal:  J Clin Endocrinol Metab       Date:  1969-07       Impact factor: 5.958

10.  The source of plasma dihydrotestosterone in man.

Authors:  T Ito; R Horton
Journal:  J Clin Invest       Date:  1971-08       Impact factor: 14.808

View more
  2 in total

1.  3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism.

Authors:  R Horton; D Hawks; R Lobo
Journal:  J Clin Invest       Date:  1982-05       Impact factor: 14.808

2.  An open label, dose response study to determine the effect of a dietary supplement on dihydrotestosterone, testosterone and estradiol levels in healthy males.

Authors:  Fru Angwafor; Mark L Anderson
Journal:  J Int Soc Sports Nutr       Date:  2008-08-12       Impact factor: 5.150

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.